scholarly journals Plasma Zinc Levels, Lipid Profile Parameters and CVD Risk Markers in Relation to Glycemic Status in T2 DM Patients

2021 ◽  
Vol 6 (3) ◽  
pp. 90-97
Author(s):  
Aman James ◽  
Nagendra S ◽  
Lata Telang
Keyword(s):  
Lipid Profile ◽  
Structural Integrity ◽  
Insulin Signalling ◽  
Atherogenic Index ◽  
Plasma Zinc ◽  
Glycemic Status ◽  
Cvd Risk ◽  
Insulin Signalling Pathway ◽  
Zinc Levels ◽  
Lipid Parameters

Background: Diabetes is global endemic rapidly increasing in both developed and developing countries and is a common secondary cause of hyperlipidaemia in T2DM patients. Diabetic- dyslipidemic patients exhibit atherogenic lipid profile, which greatly increases their CVD risk. Zinc, essential trace element, has significant function in energy metabolism and has been shown to serve a regulatory role in insulin signalling pathway and in supporting structural integrity of endothelial cells. A study designed to assess the plasma zinc status in t2 dm patients and to correlate zinc levels with lipid parameters, CVD markers as well as with glycemic status. Methods: The t2dm patients in the age group 30-60 years were randomly selected and were sub-grouped age wise, glycemic status-wise and diabetic duration-wise. Fasting Glucose, lipid parameters and zinc were estimated and atherogenic Index of Plasma (AIP), Atherogenic Coefficient (AC), and Cardiac Risk Ratio (CRR) were calculated. Results: The results shows levels of glucose, lipid parameters, AIP, AC and CRR are significantly elevated whereas the levels of HDLC and zinc are significantly lowered in t2dm patients and the rises as well as the fall in HDLC and zinc are proportional to glycemic status. Conclusion: It can be concluded from the present study that zinc levels are lower in t2dm patients and is reciprocally related to glycemic status as well as to the diabetic duration. Further the rise in CVD markers is directly proportional to the glycemic status but inversely related to CVD markers. Keywords: t2dm, CVD markers, glycemic status, zinc.

scholarly journals Lipid Profile, Atherogenic Index of Plasma, and Anthropometric Measurements Among Osteoporotic Postmenopausal Sudanese Women: Possible Risk for Cardiovascular Disease

2021 ◽  
Author(s):  
Abdelgadir Elmugadam ◽  
Ghada A. Elfadil ◽  
Abdelrahman Ismail Hamad ◽  
Mawahib Aledrissy ◽  
Hisham N. Altayb ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Lipid Profile ◽  
Postmenopausal Women ◽  
Density Lipoprotein ◽  
Anthropometric Measurements ◽  
Atherogenic Index ◽  
Cvd Risk ◽  
Atherogenic Index Of Plasma ◽  
Blood Samples ◽  
T Score

Abstract Background: Osteoporosis and menopausal women’s health had paucity data from Africa, especially Sub-Saharan countries. The current study aimed to assess the relationship between lipid profile, atherogenic Index of Plasma (AIP), anthropometric measurements, and the risk of cardiovascular disease (CVD) among osteoporotic Sudanese postmenopausal women.Methods: An epidemiological, cross-sectional comparative, community-based study was conducted. Postmenopausal women (n = 300), aged 47- 90 years, with an average one year postmenopause, were recruited from various centers in Khartoum State. Dual-energy X-ray absorptiometry (DEXA) was used to assess bone density. DEXA scan was interpreted in terms of T-score as per World Health Organization guidelines. Weight, height, and waist circumference were measured twice following standard protocols. In addition, fasting blood samples (5ml) were collected for the determination of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). AIP was calculated as an indicator for CVD risk. Blood samples were assayed on the Roche/Hitachi Cobas c311 system (Roche Diagnostics GmbH, Germany). Statistical analysis was carried out using SPSS version 26. Results: The mean age of the postmenopausal women was 61.7±10.3 years, with 80 women having normal T-score and an equal number of osteoporotic and osteopenic (n = 110 each). Most women (59%) aged 47-64 years. The prevalence of osteoporosis was 36.7%. Many postmenopausal women with normal BMD suffered from general (68%) and central obesity (94%) compared with their counterparts. Hypercholesterolemia, hypertriglyceridemia, high LDL-C, hypo-HDL-C were identified among 26.4%, 31%, 16.3%, and 32.7% osteoporotic women respectively. Osteoporotic postmenopausal (36.4%) women had medium to high risk of CVD according to their AIPs. There was a significantly inverse correlation between age and HDL-C (r= -0.205; p=0.032) whereas positive association between AIP and TC (r=0.230; p=0.016), among osteoporotic women. Osteoporotic (52%) and osteopenic (42%) women had ≥2 CVD risk factors. Multiple Linear regression analysis showed T-score value decreased significantly with age and AIP and increased with BMI. Conclusion: Osteoporosis is prevalent among Sudanese postmenopausal women who are at increased risk for CVD. Necessary steps are needed for public education and wider dissemination of information about osteoporosis, CVD and their prevention.

scholarly journals Correlation of Lipid Parameters and Markers of Insulin Resistance: Does Smoking Make a Difference?

2014 ◽  
pp. S387-S393 ◽  
Author(s):  
Ľ. CIBIČKOVÁ ◽  
D. KARÁSEK ◽  
K. LANGOVÁ ◽  
H. VAVERKOVÁ ◽  
J. ORSÁG ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Waist Circumference ◽  
Lipid Profile ◽  
Correlation Coefficients ◽  
Cross Sectional Study ◽  
Atherogenic Index ◽  
Cross Sectional ◽  
Atherogenic Index Of Plasma ◽  
Fasting Glycemia ◽  
Lipid Parameters

Insulin resistance associated with dyslipidemia enhances cardiovascular risk. Several atherogenic indexes have been suggested to give more precise information about the risk. The aim of our study was to estimate, which atherogenic index correlates better with parameters of insulin resistance. Furthermore, we compared the parameters of lipid metabolism and insulin resistance between smokers and non-smokers. In our cross-sectional study we enrolled 729 patients with dyslipidemia which were divided into two groups – non-smokers (586) and smokers (143). We measured lipid profile, parameters of insulin resistance (fasting glycemia, insulin, HOMA-IR, C-peptide, proinsulin) and calculated atherogenic indexes – atherogenic index of plasma (log (TAG/HDL-C), AIP), ApoB/ApoA1 index and nonHDL-C. AIP was found out to show stronger correlations with parameters of insulin resistance (p<0.001, correlation coefficients ranging between 0.457 and 0.243) than other indexes (ApoB/ApoA1 or nonHDL cholesterol). AIP correlated with parameters of insulin resistance both in smokers and non-smokers, but after adjustment (for age, body mass index, waist circumference) persisting only in non-smokers. Smokers had a wider waist circumference and a proatherogenic lipid profile. Smoking increases the risk of developing metabolic syndrome. AIP can be used in daily praxis for predicting insulin resistance in patients with dyslipidemia, predominantly in non-smokers.

scholarly journals Alterations in plasma lipid profile and cardiovascular risk indicators in clinically sub-grouped psoriasis

2019 ◽  
Vol 5 (2) ◽  
pp. 295 ◽  
Author(s):  
S. Srinivas ◽  
S. Nagendra ◽  
Prashanthkumar Goudappala ◽  
R. T. Kashinath
Keyword(s):  
Cardiovascular Risk ◽  
Lipid Profile ◽  
Plasma Lipid ◽  
Cardiovascular Complications ◽  
Risk Indicators ◽  
Atherogenic Index ◽  
Plasma Lipid Profile ◽  
Atherogenic Index Of Plasma ◽  
Pasi Score ◽  
Lipid Parameters

<p class="abstract"><strong>Background:</strong> Psoriasis, a chronic skin complication been considered in the recent years by dermatologists as a systemic disease with multi organ abnormalities. Dyslipidemia commonly observed in psoriasis patients may result in cardiovascular complications hence a prompt routine cardiovascular risk evaluation is essential in these patients. A study was designed to assess plasma lipid profile as well as cardiovascular risk markers in psoriasis patients to find out the relationship between cardiovascular risk indicators and psoriasis disease severity.</p><p class="abstract"><strong>Methods:</strong> Study consists of 200 subjects including 100 psoriatics. These psoriatics were sub-grouped based on their increasing PASI score into four groups.<strong></strong></p><p class="abstract"><strong>Results:</strong> The results indicate a significant elevation in lipid parameters and in cadiac risk ratio, atherogenic index of plasma as well as atherogenic coefficient in psoriatics as compared to normal controls. Further a parallel raise has seen in these lipid parameters and risk indicators based on their increasing PASI score.</p><p class="abstract"><strong>Conclusions:</strong> It can be stated from the study results that psoriatics are more affected group for cardiovascular complications and a proper evaluation of cardiovascular risk indicators in these patients is essential in preventing development of cardiovascular risk. Further the risk indicators atherogenic index of plasma and atherogenic coefficient are more promising in evaluating cardiovascular risk in psoriases patients.</p>

scholarly journals Analysis between Cigarette and Shisha Smokers for Early Atherogenesis: A Cardiovascular Disease

2021 ◽  
pp. 175-186
Author(s):  
Danish Iqbal ◽  
Izhar Wasif Burhan ◽  
Ranjay Kumar Choudhary ◽  
Mohammed Alaidarous ◽  
Bader Mohammed Alshehri ◽  
...  
Keyword(s):  
Blood Cell ◽  
Lipid Profile ◽  
Cell Count ◽  
Hematological Parameters ◽  
Atherogenic Index ◽  
Mean Corpuscular Hemoglobin ◽  
Complete Blood Cell Count ◽  
Blood Cell Count ◽  
Cigarette Smokers ◽  
Lipid Parameters

Aims: Tobacco smoking is a major health issue in Saudi Arabia, particularly among the student population. Smoking is one of the major risk factors in the genesis of coronary atherosclerosis and the development of coronary heart disease. This study aimed to evaluate the effect of cigarette and shisha smoking on atherogenic indexes, lipid profile and hematological parameters of undergraduate smokers at Majmaah University. Methodology: This cross-sectional study was conducted between November 2019 and March 2020, at the Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al-Majmaah, enrolling 100 undergraduate students (35 cigarette smokers, 30 shisha smokers, 35 non-smokers). The subjects were asked to fast overnight and early morning blood samples were collected and analyzed to measure lipid parameters, complete blood cell count and LDH. Lipid parameters were used to calculate lipid indexes and atherogenic indexes. Results: Compared with non-smokers, cigarette and shisha smokers had significantly higher levels of TC, TG, LDL-C and VLDL-C, but significantly lower levels of HDL-C. The values of comprehensive lipid indexes, including non-HDL-C, TC/HDL-C, TG/HDL-C, LDL-C/HDL-C, atherogenic index (AI), lipoprotein combine index (LCI), and atherogenic index of plasma (AIP) were all significantly higher in cigarette and shisha smokers. Hematological parameters were found to be within normal reference range, however when compared with non-smokers, cigarette and shisha smokers has significantly higher values of complete blood cell count, except for lymphocytes and mean corpuscular hemoglobin concentration (MCHC) which were significantly lower. LDH was also found to be elevated in cigarette and shisha smokers. Conclusion: The findings of this study shows that, both cigarette and shisha smokers have abnormal lipid profile suggesting dyslipidemia. Prediction of early atherosclerosis through the atherogenic indexes was observed to be significantly higher in shisha smokers than in cigarette smokers. Therefore, shisha smoking has more adverse effects on the health status of adult smokers. This study adds to the accumulating evidence on the harmful effects of shisha smoking, which is a growing epidemic among young smokers, and calls for the awareness of the possible consequences of developing early atherogenesis.

Effects of epigallocatechin-3-gallate of Camellia sinensis leaves on blood pressure, lipid profile, atherogenic index of plasma and some inflammatory and antioxidant markers in type 2 diabetes mellitus patients: a clinical trial

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Hadi Bazyar ◽  
Seyed Ahmad Hosseini ◽  
Sirous Saradar ◽  
Delsa Mombaini ◽  
Mohammad Allivand ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Lipid Profile ◽  
Atherogenic Index ◽  
Control Group ◽  
Atherogenic Index Of Plasma ◽  
The Mean

Abstract Background In patients with type 2 diabetes mellitus (T2DM) the inflammatory and metabolic responses to epigallocatechin-3-gallate (EGCG) are unknown. Objectives Evaluate the impacts of EGCG on metabolic factors and some biomarkers of stress oxidative in patients with T2DM. Methods In this randomized, double-blind, placebo-controlled trial, 50 patients with T2DM consumed either 2 tablets (300 mg) EGCG (n=25) or wheat flour as placebo (n=25) for 2 months. The total antioxidant capacity (TAC), interleukin-6 (IL-6), lipid profile, mean arterial pressure (MAP), atherogenic index of plasma (AIP) were evaluated before and after the intervention. Results The finding of present study exhibited a significant increase in the serum levels of TAC after the EGCG supplementation (p=0.001). Also, in compare with control group, the mean changes of TAC were significantly higher in supplement group (p=0.01). In intervention group, a significant decrease was observed in the mean levels of triglyceride, total cholesterol, diastolic blood pressure (DBP), AIP, and MAP (p<0.05). Taking EGCG resulted in the mean changes of total cholesterol, MAP and DBP were significantly lower in compare with control group (p<0.05). Conclusions This study recommended that EGCG supplementation may be improved blood pressure, lipid profile, AIP, and oxidative status in patients with T2DM.

scholarly journals Effects of a Paleolithic Diet on Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

2019 ◽  
Vol 10 (4) ◽  
pp. 634-646 ◽  
Author(s):  
Ehsan Ghaedi ◽  
Mohammad Mohammadi ◽  
Hamed Mohammadi ◽  
Nahid Ramezani-Jolfaie ◽  
Janmohamad Malekzadeh ◽  
...  
Keyword(s):  
Risk Factors ◽  
Blood Pressure ◽  
Cardiovascular Disease ◽  
Lipid Profile ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Cvd Risk Factors ◽  
Paleolithic Diet ◽  
Cvd Risk ◽  
Randomized Controlled

ABSTRACTThere is some evidence supporting the beneficial effects of a Paleolithic diet (PD) on cardiovascular disease (CVD) risk factors. This diet advises consuming lean meat, fish, vegetables, fruits, and nuts and avoiding intake of grains, dairy products, processed foods, and added sugar and salt. This study was performed to assess the effects of a PD on CVD risk factors including anthropometric indexes, lipid profile, blood pressure, and inflammatory markers using data from randomized controlled trials. A comprehensive search was performed in the PubMed, Scopus, ISI Web of Science, and Google Scholar databases up to August 2018. A meta-analysis was performed using a random-effects model to estimate the pooled effect size. Meta-analysis of 8 eligible studies revealed that a PD significantly reduced body weight [weighted mean difference (WMD) = −1.68 kg; 95% CI: −2.86, −0.49 kg], waist circumference (WMD = −2.72 cm; 95% CI: −4.04, −1.40 cm), BMI (in kg/m2) (WMD = −1.54; 95% CI: −2.22, −0.87), body fat percentage (WMD = −1.31%; 95% CI: −2.06%, −0.57%), systolic (WMD = −4.75 mm Hg; 95% CI: −7.54, −1.96 mm Hg) and diastolic (WMD = −3.23 mm Hg; 95% CI: −4.77, −1.69 mm Hg) blood pressure, and circulating concentrations of total cholesterol (WMD = −0.23 mmol/L; 95% CI: −0.42, −0.04 mmol/L), triglycerides (WMD = −0.30 mmol/L; 95% CI: −0.55, −0.06 mmol/L), LDL cholesterol (WMD = −0.13 mmol/L; 95% CI: −0.26, −0.01 mmol/L), and C-reactive protein (CRP) (WMD = −0.48 mg/L; 95% CI: −0.79, −0.16 mg/L) and also significantly increased HDL cholesterol (WMD = 0.06 mmol/L; 95% CI: 0.01, 0.11 mmol/L). However, sensitivity analysis revealed that the overall effects of a PD on lipid profile, systolic blood pressure, and circulating CRP concentrations were sensitive to removing some studies and to the correlation coefficients, hence the results must be interpreted with caution. Although the present meta-analysis revealed that a PD has favorable effects on CVD risk factors, the evidence is not conclusive and more well-designed trials are still needed.

scholarly journals Advanced Lipoprotein Analysis Shows Atherogenic Lipid Profile That Improves After Metreleptin in Patients with Lipodystrophy

2019 ◽  
Vol 3 (8) ◽  
pp. 1503-1517 ◽  
Author(s):  
Alexandra B Kinzer ◽  
Robert D Shamburek ◽  
Marissa Lightbourne ◽  
Ranganath Muniyappa ◽  
Rebecca J Brown
Keyword(s):  
Insulin Resistance ◽  
High Density Lipoprotein ◽  
Lipid Profile ◽  
Density Lipoprotein ◽  
High Density ◽  
Lipoprotein Profile ◽  
Cvd Risk ◽  
Lipoprotein Particles ◽  
Atherogenic Lipid Profile ◽  
Atherogenic Lipid

Abstract Context Patients with lipodystrophy have dyslipidemia and insulin resistance. Leptin treatment with metreleptin in lipodystrophy decreases insulin resistance and lowers triglycerides without changing high-density lipoprotein. Detailed measurement of lipoprotein particles with nuclear magnetic resonance (NMR) spectroscopy can offer insights into cardiovascular disease (CVD) risk and lipid metabolism beyond a standard lipid panel. We hypothesized that patients with lipodystrophy would have a more atherogenic lipid profile than controls at baseline, which would be ameliorated with metreleptin treatment. Objective To characterize the lipoprotein profile in patients with lipodystrophy compared with controls and to evaluate effects of metreleptin treatment. Design, Setting, Patients, and Intervention Patients with lipodystrophy (N = 17) were studied before and after metreleptin for 2 weeks and 6 months and compared with 51 insulin-sensitive sex-matched controls. Main Outcome Measures Lipoprotein profiles were measured by NMR with the LP4 deconvolution algorithm, which reports triglyceride-rich lipoprotein particles (TRLPs), high-density lipoprotein particles (HDLPs), and low-density lipoprotein particles (LDLPs). Results Patients with lipodystrophy had elevated large TRLPs and smaller HDLPs and LDLPs compared with controls. Five patients with lipodystrophy had chylomicrons, compared with zero controls. Metreleptin decreased the size and concentration of TRLPs, eliminated chylomicrons in all but one patient, decreased LDLPs, and increased LDLP size. Metreleptin treatment did not have major effects on HDLPs. Conclusions Patients with lipodystrophy had an atherogenic lipoprotein profile at baseline consistent with elevated CVD risk, which improved after metreleptin treatment. The presence of fasting chylomicrons in a subset of patients with lipodystrophy suggests saturation of chylomicron clearance by lipoprotein lipase.

scholarly journals The insulin signalling pathway

2002 ◽  
Vol 12 (7) ◽  
pp. R236-R238 ◽  
Author(s):  
Jose M. Lizcano ◽  
Dario R. Alessi
Keyword(s):  
Insulin Signalling ◽  
Signalling Pathway ◽  
Insulin Signalling Pathway
Sign in / Sign up

Export Citation Format

Share Document